Patents

US 9669004 B2: Daidzein analogs as treatment for cancer

Granted
2017-06-06
Filed
2015-01-15 application 14597252
Type
Utility · 24 claims
Elsewhere
Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗

Abstract

Provided are compositions for treatment of cancers, including breast cancer, comprising at least one novel daidzein analog, as well as methods of using the same for preventing or treating cancer or tumor growth.

Source: PVGPATDIS, file of 2026-04-10 (ipg170606.xml).

Assignees

AssigneeTypePlaceAlso on furp.orgSource
The Administrators of the Tulane Educational Fund 124 patentsUS company or organizationNew Orleans, LAThe Administrators of the Tulane Educational Fund State business registration EXACT high confidence: identical full name and state
Tulane University of Louisiana College or university EXACT high confidence: through the nonprofit with the college's EIN (identical full name and state)
THE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND Nonprofit EXACT high confidence: identical full name and state
PVGPATDIS, file of 2026-04-10
United States Department of Agriculture 3 patentsUS company or organizationNew Orleans, LAPVGPATDIS, file of 2026-04-10
Xavier University of Louisiana 14 patentsUS company or organizationNew Orleans, LAXavier University of Louisiana College or university EXACT high confidence: identical full name and state
XAVIER UNIVERSITY OF LOUISIANA Nonprofit EXACT high confidence: identical full name and state
PVGPATDIS, file of 2026-04-10

Inventors

InventorPlacePatentsPerson pageSource
Guangdi WangNew Orleans, LA11PVGPATDIS, file of 2026-04-10
Matthew E. BurowNew Orleans, LA9PVGPATDIS, file of 2026-04-10
Stephen M. BoueNew Orleans, LA8PVGPATDIS, file of 2026-04-10
Thomas E. WieseNew Orleans, LA3PVGPATDIS, file of 2026-04-10
Quan JiangNew Orleans, LA7PVGPATDIS, file of 2026-04-10

CPC categories

SubclassCategoryFirst groupSource
A61KPreparations for medical, dental or toiletry purposesA61K31/353PVGPATDIS, file of 2026-04-10
A61PSpecific therapeutic activity of chemical compounds or medicinal preparationsA61P35/00PVGPATDIS, file of 2026-04-10
C07DHeterocyclic compoundsC07D311/38PVGPATDIS, file of 2026-04-10

Cooperative Patent Classification, as currently assigned (one row per subclass).

Assignments and security interests

RecordedWhatFromToReel/frameSource
2015-02-25Assignment
Assignment of assignor's interest
BOUE, STEPHEN M. signed 2013-03-05
JIANG, QUAN signed 2013-03-05
WANG, GUANGDI signed 2013-03-05
BUROW, MATHEW E. signed 2013-03-11
WIESE, THOMAS E. signed 2013-03-12
THE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND NEW ORLEANS, LA
UNITED STATES DEPARTMENT OF AGRICULTURE NEW ORLEANS, LA
XAVIER UNIVERSITY OF LOUISIANA NEW ORLEANS, LA
35023/722ECORSEXC, file of 2026-09-25

Documents recorded with the USPTO Assignment Recordation Branch that list this patent. A security interest is a lender’s claim on the patent as collateral; a release ends it.

USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.